US 12070460
Methods of treating skin cancer with Carboxypeptidase Vitellogenic Like (CPVL) inhibitors
granted A61KA61K31/506A61K31/713
Quick answer
US patent 12070460 (Methods of treating skin cancer with Carboxypeptidase Vitellogenic Like (CPVL) inhibitors) held by REGENERON PHARMACEUTICALS, INC. expires Mon Aug 22 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- REGENERON PHARMACEUTICALS, INC.
- Grant date
- Tue Aug 27 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Aug 22 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 8
- CPC classes
- A61K, A61K31/506, A61K31/713, A61K45/06, A61P